Demo creative for Header leaderboard (728x90)

Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

MarketWatch
Image: MarketWatch

As part of the agreement, Hims said it won’t compound GLP-1 medications like Zepbound in the future.

Demo creative for Between results (336x280)